Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Marcela Moretton"'
Autor:
María Jimena Salgueiro, Mariano Portillo, Fiorella Tesán, Melisa Nicoud, Vanina Medina, Marcela Moretton, Diego Chiappetta, Marcela Zubillaga
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 9, Iss 1, Pp 1-17 (2024)
Abstract Background Previous studies employing polymeric micelles and molecular imaging for in vivo nanosystem characterization have led to the development of radionanoprobes (RNPs) designed for diagnosing and monitoring therapeutic interventions in
Externí odkaz:
https://doaj.org/article/916e659ee25245adbe00bcc01d8d89d7
Autor:
Oriana Boscolo, Sabrina Flor, Leandro Salvo, Cecilia Dobrecky, Christian Höcht, Valeria Tripodi, Marcela Moretton, Silvia Lucangioli
Publikováno v:
Pharmaceutics, Vol 15, Iss 8, p 2037 (2023)
Background: Ursodeoxycholic acid (UDCA) is a therapeutic agent used for the treatment of cholestatic hepatobiliary diseases in pediatric patients. It is a bile acid that presents high lipophilicity, and it belongs to Class II of the Biopharmaceutical
Externí odkaz:
https://doaj.org/article/341cf184cafb47dc9259135af3bc63b5
Autor:
Maria Natalia Calienni, Daniela Maza Vega, C. Facundo Temprana, María Cecilia Izquierdo, David E. Ybarra, Ezequiel Bernabeu, Marcela Moretton, Fernando C. Alvira, Diego Chiappetta, Silvia del Valle Alonso, María Jimena Prieto, Jorge Montanari
Publikováno v:
Pharmaceutics, Vol 13, Iss 2, p 186 (2021)
Vismodegib is a first-in-class inhibitor for advanced basal cell carcinoma treatment. Its daily oral doses present a high distribution volume and several side effects. We evaluated its skin penetration loaded in diverse nanosystems as potential strat
Externí odkaz:
https://doaj.org/article/a278a51188c342faa11e9efac5cf2da4
Autor:
Miguel Angel Allo, Yanina Santander Plantamura, Ezequiel Bernabeu, Eliana Bin, Marcela Moretton, Andrea Carranza, Diego Chiapetta, Christian Höcht
Publikováno v:
Revista Argentina de Cardiologia. 90:34-39
Background: In our laboratory, we have developed subcutaneous implants of carvedilol capable of maintaining stable concentrations of the β-blocker during 3 weeks. Objective: The aim of this study was to evaluate the in vivo release and the cardiopro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37825855c760f6e39b32bd41dc017301
https://doi.org/10.7775/rac.v90.i1.20478
https://doi.org/10.7775/rac.v90.i1.20478
Autor:
Miguel Angel Allo, Yanina Santander Plantamura, Ezequiel Bernabeu, Eliana Bin, Marcela Moretton, Andrea Carranza, Diego Chiapetta, Christian Hocht
Publikováno v:
Revista Argentina de Cardiologia. 90:36-42
Introducción: En nuestro laboratorio hemos desarrollado implantes subcutáneos de carvedilol capaces de mantener niveles plasmáticos sostenidos del β-bloqueante durante 3 semanas. Objetivo: Evaluación de la liberación in vivo y la eficacia cardi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9c25b0c6c3ca5e5dfd98e5769cd0d67
https://doi.org/10.7775/rac.es.v90.i1.20478
https://doi.org/10.7775/rac.es.v90.i1.20478